Menu Back toSession-9-Hot-Topics

Pharmacovigilance and Risk Management Strategies Conference


Session 5: Hot Topics – Handling Emerging Trends in Pharmacovigilance

Session Chair(s)

Barbara  Morollo, RN

Barbara Morollo, RN

  • Head, Pharmacovigilance
  • Corbus Pharmaceuticals, United States
Catherine  Baldridge, MSc

Catherine Baldridge, MSc

  • Founder/Owner, Principal Consultant
  • Essential Pharmacovigilance, LLC, United States
This session will explore three hot topics and emerging trends in pharmacovigilance which include spanning discussions regarding predictive safety using translational data and non-clinical data for predicting ADRs, the impact of cannabinoids as therapeutics and research into the endocannabinoid system.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the technology and factors that contribute to the ability to predict an adverse events or adverse event in a specific population
  • Identify the unique regulatory challenges surrounding cannabis and studying therapeutic benefits in investigational research

Speaker(s)

Barbara  Morollo, RN

Cannabinoids as Therapeutics

Barbara Morollo, RN

  • Head, Pharmacovigilance
  • Corbus Pharmaceuticals, United States
Glenn  Carroll, MBA

Speaker

Glenn Carroll, MBA

  • Principal, Strategy | Life Sciences
  • Deloitte, United States
Sarah  Vaughan

Yellow Card Biobank

Sarah Vaughan

  • Pharmacovigilance Information Unit Systems Manager
  • Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom